The lack of effective prevention of aGVHD by host-tissue PD-L1 may result from the cytokine environment, since GVHD target tissues express elevated levels of IL-2, IFN-γ, TNF-α, GM-CSF, and IL-6 (7, 158). The gene discussed is IL6; the disease is graft versus host disease.